Health
Study: Thymoquinone selectively kills prostate cancer cells at advanced stages – News-Medical.Net
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene.
Reviewed by Emily Henderson, B.Sc.Oct 8 2020
The compound thymoquinone (TQ) selectively kills prostate cancer cells at advanced stages, according to a new study published in Oncogene. Led by researchers at Kanazawa University, the study reports that prostate cancer cells with a deletion of the SUCLA2 gene can be therapeutically targeted.
SUCLA2-deficient prostate cancers represent a significant fraction of those resistant to hormone therapy or metastatic, and a new therapeutic option for this …
-
General16 hours agoQantas terminal at Melbourne Airport evacuated and flights delayed due to fire
-
Business23 hours ago$10,000 invested in Woodside shares 4 years ago is now worth…
-
Business21 hours ago3 of the best ASX ETFs for beginners to buy with $1,000
-
Business19 hours agoWhy this ASX 200 tech stock could rise 20%